Johnson & Johnson is joining the hunt for drugs to treat dengue fever - the world's fastest-spreading tropical disease - by entering pharma deals with academic researchers in Belgium and the Wellcome Trust medical charity. Read the full story

Takeda creates m&a news with Inviragen, entering into a definitive agreement for the acquisition of Inviragen in $250 million m&a deals. Read the full story

The Dengue Fever Partnering provides understanding and access to the dengue fever partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story